ANI Pharmaceuticals, Inc.

NASDAQ (USD): ANI Pharmaceuticals, Inc. (ANIP)

Last Price

60.38

Today's Change

-0.67 (1.09%)

Day's Change

60.09 - 62.06

Trading Volume

223,157

Profile
ANIP

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Nikhil Lalwani Mr. Nikhil Lalwani

Full Time Employees:  642 642

IPO Date:  2000-05-05 2000-05-05

CIK:  0001023024 0001023024

ISIN:  US00182C1036 US00182C1036

CUSIP:  00182C103 00182C103

Beta:  0.71 0.71

Last Dividend:  0.00 0.00

Dcf Diff:  127.09 127.09

Dcf:  -63.34 -63.34

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Address

210 Main Street West,
Baudette, MN 56623, US

218 634 3500

http://www.anipharmaceuticals.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment